A highly polymethylated flavone that effectively inhibited cytochrome P450s (CYPs) 1A2 and 3A4 (IC 50 ¼ 2:41 and 1.71 M) in vitro was isolated from thyme leaves (Thymus saturoides) purchased from a Japanese market. Its structure was spectroscopically identified as 4 0 ,5-dihydroxy-3 0 ,6,7,8-tetramethoxy flavone (8-methoxycirsilineol, 1). This is the first report describing a strong inhibitor of CYP1A2 and 3A4 isolated from Thymus saturoides.
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Key words: 8-methoxycirsilineol; cytochrome P450 (CYP) inhibitor; Thymus saturoides; polymethoxyflavone Pharmacological and chemical investigations of aromatic and medicinal plants have provided important advances in the therapeutic approach to several types of pathology. Thyme is a well-known medicinal plant used worldwide as an aromatic herb to add a distinctive aroma and flavor to food. The leaves can be used fresh or dried as a spice. [1] [2] [3] The majority of the thyme species possess various beneficial effects and have antiseptic, antimicrobial, antifungal and antioxidative properties. [1] [2] [3] [4] [5] [6] Cytochrome P450 monooxygenases (CYPs), a large ubiquitous enzyme family with a heme structure, are involved in the hepatic metabolism of xenobiotic lipophilic substances. CYPs are the key enzymes catalyzing the oxidative metabolism of a large number of exogenous compounds for detoxifying toxic, carcinogenic, and most pharmaceutical agents. The extrahepatic expression of CYPs has recently been established, and certain CYPs involved in hormone and vitamin metabolism and in the metabolic activation of genotoxic substances have been reported to have important roles in tumor formation and development. [7] [8] [9] [10] Food materials with effective inhibitors against CYPs are potential candidates for cancer prevention strategies.
We investigated the active compounds against CYPs in the leaves of common thyme purchased from a Japanese market to advance strategies using functional foods that would either inhibit or exploit CYP enzymes for treating cancer. We describe here the isolation, identification, and inhibitory activities of an active compound (1) against CYPs 1A2, 2D6, and 3A4.
The dry leaves (200 g) of thyme purchased from a Japanese market (Thymus saturoides, S&B Foods, Tokyo, Japan) were soaked at room temperature for 24 h in 80% acetone (4 L). The resulting filtrate was evaporated in vacuo to an aqueous concentrate and then extracted three times with equal volumes of ethyl acetate (EtOAc) at pH 3.0 to give an EtOAc extract (14.6 g, IC 50 ¼ 6:59 AE 0:81 mg/mL). This extract was subjected to Sephadex LH-20 column chromatography, eluting with methanol as the solvent, to give a CYP3A4-active fraction (980.3 mg) which had inhibitory activity of 79:9 AE 0:8% at 7.0 mg/mL. This active fraction was purified by repetitive preparative TLC, developed by using solvent systems of chloroform-methanol (9:1) and hexane-EtOAc (1:1), and an active compound (1, 4.4 mg) was obtained.
The active compound (1) isolated from thyme was identified as a yellow amorphous powder with the molecular formula of C 19 (1) has previously been isolated from the Sideritis genus 11) and Thymus species, [12] [13] [14] [15] as well as from such other plant species as the Egyptian medicinal y To whom correspondence should be addressed. Fax: +81-3-5477-2674; E-mail: abe@nodai.ac.jp Abbreviations: TLC, thin layer chromatography; HRESI-MS, high resolution electron spray ionization mass spectrometry
Note plant, Cleome droserifolia, and the Chinese herb, Rabdosia rubescen. 16, 17) The chemical structure of 1 was similar to that of nobiletin (2, Fig. 1), 3 0 ,4 0 ,5,6,7,8-hexamethoxyflavone. Compound 2 is a major component of the polymethoxyflavone family of citrus fruits, and has important protective biological properties, including anticancer, anti-inflammatory and antiatherogenic activities. There is thus strong interest in 2 as a functional food factor (Fig. 1) . Compound 2 does not inhibit CYP3A4.
18) The inhibitory effects of compounds 1 and 2 and other flavonoids on CYP1A2, CYP2D6, and CYP3A4 were investigated (Table 1) . These inhibitory effects were determined by using black 96-well microtiter plates (Sumitomo Bakelite, Tokyo, Japan) based on the formation of fluorescent metabolites by the CYP enzymes. CYP inhibitory activity was assayed by using the Vivid CYP Blue substrate. 7-Ethyloxymethyloxy-3-cyanocoumarin was the substrate used with CYP1A2 and CYP2D6, and 7-benzyloxymethyloxy-3-cyanocoumarin was used with CYP3A4. The positive controls were safrole for CYP1A2, cimetidine for CYP2D6 and erythromycin for CYP3A4. 19) Safrole was purchased from Tokyo Kasei Kogyo (Tokyo, Japan), and apigenine, erythromycin, nobiletin and other reagents were obtained from Wako Pure Chemical Industries (Osaka, Japan). Cimetidine, fisetin, kaempferol, luteolin and quercetin were from Sigma Chemicals (St. Louis, MO, USA), and chrysin was from Kanto Chemical Industry Co. (Tokyo, Japan). All other reagents were of the best grade commercially available.
8-Methoxycirsilineol 1 and nobiletin 2 showed dosedependent inhibitory activity toward CYPs, both compounds inhibiting the CYP1A2 enzyme activity in vitro. Compound 2 showed the second strongest CYP1A2 inhibitory activity toward all the tested compounds, following that of chrysin 5, with an IC 50 value of 0:83 AE 0:17 mM, this being much stronger than that of the positive control, safrole (IC 50 ¼ 3:87 AE 0:7 mM). Compound 1 was a potent inhibitor of CYP1A2 with an IC 50 value of 2:41 AE 0:33 mM. However neither compound 1 nor 2 showed any inhibitory activity toward CYP2D6 at concentrations of less than 100 mM, unlike compound 1 which had the most potent inhibitory effect of all the tested compounds on CYP3A4 (IC 50 ¼ 1:71 AE 0:33 mM), similar to that of the positive control, erythromycin (IC 50 ¼ 2:09 AE 0:2 mM) and much stronger than that of 2 which had an IC 50 value of 20:6 AE 5:2 mM (Table 1 ). These findings indicate that 8-methoxycirsilineol 1 and nobiletin 2 had inhibitory effects on CYP1A2 with nearly the same potency, but no inhibitory activity toward CYP2D6, unlike such flavonols possessing a 3-OH group as quercetin 6, kaempferol 7, and fisetin 8 which showed inhibitory activities. Compound 1 also had the most potent inhibitory activity toward CYP3A4, stronger than that of compound 2. Inhibitory activity is strongly influenced by the presence and/or position of hydroxyl groups on the A, B, and C rings of flavonoids. Studies on the substituent effect at C-4 0 of flavonoids have suggested that the hydroxy group had more effective CYP 3A inhibitory activity than the methoxy or hydrogen group. 20) The hydroxy groups at C-5 and C-4 0 of compound 1 might have been particularly important for its strong inhibitory activity against CYP3A4. CYP3A4 is the most abundant CYP expressed in the human liver and the small intestine, and plays a dominant role in both drug metabolism and metabolic activation of such carcinogens as aflatoxin B 1 and polycyclic hydrocarbons. 21 ) Nobiletin 2 and tangeretin, both permethylated polymethoxyflavones, stimulate many-fold the metabolism of benzo[]pyrene and aflatoxin B 1 in human liver microsomes, whereas apigenin 4, chrysin 5, quercetin 6, kaempferol 7, and fisetin 8 inhibit the metabolism of these compounds in vitro.
22) The substituent effects of flavones on the metabolic activation of carcinogens are complicated both in vitro and in vivo.
23) Different effects of the flavones against CYP isozymes may mainly depend on differences in their active site cavities. The crystal structures of human CYP1A2, 24) CYP3A4, 25) and CYP2D6 26) isozymes have been reported. Such polymethoxyflavones as nobiletin 2 and tangeretin have been reported to have significant biological activities, and comparative studies on partially demethylated polymethoxyflavones are therefore important to determine the structure-activity relationship.
A previous study has indicated the ability of 8-methoxycirsilineol 1 to inhibit the chemical mediator release from rat basophilic leukemia RBL-2H3 cells. 14) Cytotoxicity against the HL-60 cancer cell line 17) and the antioxidative activity of 1 have also been reported. 15, 27) We report here for the first time that compound 1 exhibited strong CYP inhibitory effects in vitro on the three CYP isozymes, CYPs 1A2, 2D6, and 3A4, particularly on CYP1A2 and CYP3A4. These results suggest that thyme (Thymus saturoides) purchased from the Japanese market does not only have negative effects on numerous food-drug interactions, but can also become a significant food material for preventing cancer through inhibition of the metabolic activation of carcinogens.
